The Indian Practitioner

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Role of Trimetazidine in Preventing Myocardial Injury in Patients Undergoing Off Pump CABG


Affiliations
1 Mch CTVS, Assistant Professor, Era Medical College, India
2 KGMU Cardiology, Lucknow, India
3 Batra Hospital & Medical Research Center, New Delhi, India
     

   Subscribe/Renew Journal


No Abstract.

Keywords

No Keywords.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Saha KK.Off-pump coronary bypass grafting: the new gold standard. Indian J Thoracic Cardiovasc Surg.2018;34:3–5.

  • Hoffman JW Jr, et al. Myocardial reperfusion injury: etiology, mechanisms, and therapies. J Extra Corpor Technol. 2004;36:391-411.

  • Zhang N, Lei J, Liu Q, Huang W, Xiao H, Lei H. The effectiveness of preoperative trimetazidine on myocardial preservation in coronary artery bypass graft patients: a systematic review and meta-analysis. Cardiology. 2015;131:86-96.

  • Kantor PF, Lucien A, Kozak R, Lopaschuk GD. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme - A thiolase. Circ Res. 2000;86(5):580-88.

  • Turk T, Ata Y, Ufuk A, Hasan A, Kagan A, Senol Y. Efficacy of preoperative trimetazidine for preventing myocardial injury in patients undergoing off-pump coronary artery bypass grafting. Eur Res J. 2016;2:107-111.22222


Abstract Views: 51

PDF Views: 0




  • Role of Trimetazidine in Preventing Myocardial Injury in Patients Undergoing Off Pump CABG

Abstract Views: 51  |  PDF Views: 0

Authors

Khalid Iqbal
Mch CTVS, Assistant Professor, Era Medical College, India
Irshad Wani
KGMU Cardiology, Lucknow, India
Bashir Amhad
Batra Hospital & Medical Research Center, New Delhi, India

Abstract


No Abstract.

Keywords


No Keywords.

References